Maven Securities’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,500
Closed -$1.97M 666
2025
Q2
$1.97M Buy
+7,500
New +$1.83M 0.05% 313
2024
Q1
Sell
-4,900
Closed -$1.11M 697
2023
Q4
$1.11M Buy
4,900
+400
+9% +$84K 0.02% 444
2023
Q3
$905K Buy
+4,500
New +$949K 0.01% 650
2023
Q2
Sell
-1,397
Closed -$275K 968
2023
Q1
$275K Buy
+1,397
New +$287K 0.01% 819

Other funds holding LH

Maven Securities's LH Position: Q4 2024 in Review

Maven Securities sold out of Labcorp (LH) in Q4 2024, closing a stake of 1,005 shares — an estimated $225K sold.

Maven Securities first reported a position in LH in Q1 2023 and held it in 4 quarters. The position peaked at $307K in Q1 2023. 923 funds tracked by Wall St. Rank hold LH as of Q4 2024.

  • Maven Securities reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
  • Maven Securities sold 1,005 Labcorp shares in Q4 2024, an estimated $225K.
  • Maven Securities first reported a position in Labcorp in Q1 2023 and held it in 4 quarters.
  • Maven Securities's Labcorp position peaked at $307K in Q1 2023.
  • 923 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.